354. Macea, D.D., et al.
The efficacy of Web-based cognitive behavioral interventions for chronic pain: a
systematic review and meta-analysis. J Pain, 2010. 11: 917.
https://pubmed.ncbi.nlm.nih.gov/20650691/
355. Stakeholder feedback from the Cochrane Pain, Palliative and Supportive Care (PaPaS) Review
Group on the National Institute of Health and Care Excellence (NICE) draft clinical guideline GID-
NG10069. Chronic pain: assessment and management. 2020.
https://www.semanticscholar.org/paper/Stakeholder-feedback-from-the-Cochrane-Pain%2C-and-
on/596a9050abe5f38a48ec08ba8dc52603448e890b
356. Shoskes, D.A., et al. Phenotypically directed multimodal therapy for chronic prostatitis/chronic
pelvic pain syndrome: a prospective study using UPOINT. Urology, 2010. 75: 1249.
https://pubmed.ncbi.nlm.nih.gov/20363491/
357. Nickel, J.C., et al. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a
randomized double blind trial. J Urol, 2004. 171: 1594.
https://pubmed.ncbi.nlm.nih.gov/15017228/
358. Zhao, W.P., et al. Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome
(Category IIIA). Braz J Med Biol Res, 2009. 42: 963.
https://pubmed.ncbi.nlm.nih.gov/19787151/
359. Bates, S.M., et al. A prospective, randomized, double-blind trial to evaluate the role of a short
reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic
pain syndrome. BJU Int, 2007. 99: 355.
https://pubmed.ncbi.nlm.nih.gov/17313424/
360. Cheah, P.Y., et al. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a
randomized, placebo controlled trial. J Urol, 2003. 169: 592.
https://pubmed.ncbi.nlm.nih.gov/12544314/
361. Gul, O., et al. Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by
prostatitis symptom score index. Int Urol Nephrol, 2001. 32: 433.
https://pubmed.ncbi.nlm.nih.gov/11583367/
362. Mehik, A., et al. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a
prospective, randomized, double-blind, placebo-controlled, pilot study. Urology, 2003. 62: 425.
https://pubmed.ncbi.nlm.nih.gov/12946740/
363. Evliyaoglu, Y., et al. Lower urinary tract symptoms, pain and quality of life assessment in chronic
non-bacterial prostatitis patients treated with alpha-blocking agent doxazosin; versus placebo. Int
Urol Nephrol, 2002. 34: 351.
https://pubmed.ncbi.nlm.nih.gov/12899226/
364. Tugcu, V., et al. A placebo-controlled comparison of the efficiency of triple- and monotherapy in
category III B chronic pelvic pain syndrome (CPPS). Eur Urol, 2007. 51: 1113.
https://pubmed.ncbi.nlm.nih.gov/17084960/
365. Chen, Y., et al. Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain
syndrome: a multicenter, randomized trial. World J Urol, 2011. 29: 381.
https://pubmed.ncbi.nlm.nih.gov/20336302/
366. Nickel, J.C., et al. A randomized placebo-controlled multicentre study to evaluate the safety and
efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial
prostatitis). BJU Int, 2004. 93: 991.
https://pubmed.ncbi.nlm.nih.gov/15142149/
367. Anothaisintawee, T., et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a
systematic review and network meta-analysis. JAMA, 2011. 305: 78.
https://pubmed.ncbi.nlm.nih.gov/21205969/
368. Cohen, J.M., et al. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/
CPPS): A systematic review and meta-analysis. PLoS ONE, 2012. 7: e41941.
https://pubmed.ncbi.nlm.nih.gov/22870266/
369. Nickel, J.C., et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N
Engl J Med, 2008. 359: 2663.
https://pubmed.ncbi.nlm.nih.gov/19092152/
370. Nickel, J.C., et al. Predictors of patient response to antibiotic therapy for the chronic prostatitis/
chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol, 2001. 165: 1539.
https://pubmed.ncbi.nlm.nih.gov/11342913/
371. Lee, J.C., et al. Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not
differ from those of healthy controls. J Urol, 2003. 169: 584.
https://pubmed.ncbi.nlm.nih.gov/12544312/
76 CHRONIC PELVIC PAIN - LIMITED UPDATE MARCH 2022